Inventor
JOHN E. BISI
Inventor
US
Overview
Patents· 3 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes60%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations40%
PatentTitleYear
12,285,431Treatment of Rb-negative tumors using topoisomerase inhibitors in combination with cyclin dependent kinase 4/6 inhibitors202511,446,295Anti-neoplastic combinations and dosing regimens using CDK4/6 inhibitor compounds to treat Rb-positive tumors202211,395,821Treatment of EGFR-driven cancer with fewer side effects2022Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2022–2025Patents assigned to G1 THERAPEUTICS INC (3)· patent assignee history
2022–2025Based in US· patent location history
2025Patents assigned to PHARMACOSMOS HOLDING AS (1)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| G1 THERAPEUTICS INC | 3 | 2022–2025 |
| PHARMACOSMOS HOLDING AS | 1 | 2025 |
Locations
| Location | Patents | Span |
|---|---|---|
| US | 3 | 2022–2025 |